Matthew Kacsmaryk
Matthew Kacsmaryk at the Senate Judiciary Committee's nomination hearing on December 13, 2017.
  • Judge Matthew Kacsmaryk is overseeing a lawsuit that challenges the FDA approval of mifepristone.
  • A ruling could have nationwide implications for the drug's availability.
  • A hearing was scheduled for Wednesday, but the judge hoped to delay publicizing the date, per WaPo.

A hearing for a lawsuit that could have significant outcomes for a government-approved abortion pill, mifepristone, has been scheduled for Wednesday.